Steatohepatitis/Metabolic Liver Disease

Top Story

Viking Therapeutics NAFLD therapy achieves significant liver fat reduction

September 19, 2018
In the Journals

Liquid biopsy identifies chronic liver disease, liver cancer vs. healthy blood

September 13, 2018
A recently developed liquid biopsy cell-sorting device was able to detect circulating epithelial cells of hepatocyte origin in blood from healthy individuals, patients…

Bird Rock Bio completes nimacimab phase 1 final patient visit for NAFLD

September 13, 2018
Bird Rock Bio completed its final patient visit in a phase 1b ascending dose trial of nimacimab for treating patients with nonalcoholic fatty liver disease and diabetes…

Guest Commentary: Drug abuse, obesity prevention begins with children

September 11, 2018
In this guest commentary from the Liver Health Initiative, Thelma King Thiel, RN, BA, former CEO of both the American Liver Foundation and the
More Headlines »
CME

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Chapter 40: Progressive Ascites In a Patient From Sierra Leone

From Complicated Cases in GI
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News

VIDEO: AASLD to speak on Capitol Hill on the public health burden of NAFLD

October 24, 2017
More »